October 2005
Combination of Cisplatin and Raltitrexed Improves Survival with Mesothelioma
According to the results of a phase III clinical trial published in the Journal of Clinical Oncology, treatment with both cisplatin and raltitrexed results in better survival among patients with malignant pleural mesothelioma than treatment with cisplatin alone.



